ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A 12 Week, Randomized, Double-blind, Placebo-controlled, Phase II Trial to Evaluate the Efficacy and Safety of the Treatment With BPL-1 in Adult Patients With Type 2 Diabetes Mellitus With Different Course of Disease and Treatment
Case Medical Research
◽
10.31525/ct1-nct04191525
◽
2019
◽
Author(s):
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Phase Ii
◽
Phase Ii Trial
◽
Efficacy And Safety
◽
Double Blind
◽
Course Of Disease
◽
Double Blind Placebo
Download Full-text
Related Documents
Cited By
References
Empagliflozin Monotherapy in Japanese Patients with Type 2 Diabetes Mellitus: a Randomized, 12-Week, Double-Blind, Placebo-Controlled, Phase II Trial
Advances in Therapy
◽
10.1007/s12325-014-0126-8
◽
2014
◽
Vol 31
(6)
◽
pp. 621-638
◽
Cited By ~ 48
Author(s):
Takashi Kadowaki
◽
Masakazu Haneda
◽
Nobuya Inagaki
◽
Yasuo Terauchi
◽
Atsushi Taniguchi
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Phase Ii
◽
Phase Ii Trial
◽
Japanese Patients
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study
Diabetologia
◽
10.1007/s00125-021-05460-0
◽
2021
◽
Author(s):
Linong Ji
◽
Ying Du
◽
Min Xu
◽
Xiangjun Zhou
◽
Zhaohui Mo
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Phase Ii
◽
Controlled Study
◽
Efficacy And Safety
◽
Double Blind
◽
Treatment Naïve
Download Full-text
Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong
Journal of Diabetes
◽
10.1111/1753-0407.12425
◽
2016
◽
Vol 9
(4)
◽
pp. 386-395
◽
Cited By ~ 10
Author(s):
Changyu Pan
◽
Ping Han
◽
Qiuhe Ji
◽
Chengjiang Li
◽
Juming Lu
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Hong Kong
◽
Mainland China
◽
Efficacy And Safety
◽
Phase 3
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial
Diabetes Obesity and Metabolism
◽
10.1111/dom.12047
◽
2013
◽
Vol 15
(5)
◽
pp. 432-440
◽
Cited By ~ 90
Author(s):
K. Kaku
◽
S. Inoue
◽
O. Matsuoka
◽
A. Kiyosue
◽
H. Azuma
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Glycaemic Control
◽
Controlled Trial
◽
Japanese Patients
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Efficacy and safety of Glycebal (PDM011011) capsules as adjuvant therapy in subjects with type 2 diabetes mellitus: an open label, randomized, active controlled, phase II trial
Clinical Diabetology
◽
10.5603/dk.2016.0015
◽
2016
◽
Vol 5
(3)
◽
pp. 88-94
◽
Cited By ~ 1
Author(s):
Ashish C. Suthar
◽
Anand Deshmukh
◽
Vijaya Babu
◽
Vijaya S. Mohan
◽
Madhukar V. Chavan
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Adjuvant Therapy
◽
Phase Ii
◽
Phase Ii Trial
◽
Efficacy And Safety
◽
Open Label
Download Full-text
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients with Type 2 Diabetes Mellitus
Global Journal of Endocrinological Metabolism
◽
10.31031/gjem.2018.02.000543
◽
2018
◽
Vol 2
(4)
◽
Author(s):
Davis Townsend
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Controlled Trial
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial
Diabetes Obesity and Metabolism
◽
10.1111/dom.12898
◽
2017
◽
Vol 19
(6)
◽
pp. 874-882
◽
Cited By ~ 28
Author(s):
Takashi Kadowaki
◽
Nobuya Inagaki
◽
Kazuoki Kondo
◽
Kenichi Nishimura
◽
Genki Kaneko
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Controlled Trial
◽
Japanese Patients
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Efficacy and safety of linagliptin as add‐on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled trial
Diabetes Obesity and Metabolism
◽
10.1111/dom.14231
◽
2020
◽
Author(s):
Wenying Yang
◽
Xiangjin Xu
◽
Tao Lei
◽
Jianhua Ma
◽
Ling Li
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Controlled Trial
◽
Chinese Patients
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period
Expert Opinion on Pharmacotherapy
◽
10.1080/14656566.2017.1359259
◽
2017
◽
Vol 18
(13)
◽
pp. 1291-1300
◽
Cited By ~ 16
Author(s):
Takashi Kadowaki
◽
Kazuoki Kondo
◽
Noriyuki Sasaki
◽
Kyoko Miyayama
◽
Shoko Yokota
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Controlled Trial
◽
Japanese Patients
◽
Efficacy And Safety
◽
Open Label
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J-STEP/INS): Results of a 16-week randomized, double-blind, placebo-controlled multicentre trial
Diabetes Obesity and Metabolism
◽
10.1111/dom.12957
◽
2017
◽
Vol 19
(10)
◽
pp. 1397-1407
◽
Cited By ~ 23
Author(s):
Yasuo Terauchi
◽
Masahiro Tamura
◽
Masayuki Senda
◽
Ryoji Gunji
◽
Kohei Kaku
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Glycaemic Control
◽
Multicentre Trial
◽
Japanese Patients
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close